Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02512666 · ClinicalTrials.gov registry record · NA
Non Invasive Optical Imaging of WBC Count
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT02512666: Completed NA study, sponsored by Massachusetts General Hospital.
NCT02512666 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02512666, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
This research study is looking at a small device that measures white blood cell (WBC) counts by being placed against the finger nail for participants who are undergoing stem cell transplantation at Massachusetts General Hospital or have a hematologic malignancy and are being seen as an outpatient.
Interventions
- DEVICE AM4113-N5UT Dino-Lite
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2015-09 |
| Est. Completion | 2017-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02512666
The ClinicalTrials.gov registry entry for NCT02512666 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AM4113-N5UT Dino-Lite is the first listed.
NCT02512666 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02512666 about?
NCT02512666 is a clinical study titled "Non Invasive Optical Imaging of WBC Count". This research study is looking at a small device that measures white blood cell (WBC) counts by being placed against the finger nail for participants who are undergoing stem cell transplantation at Massachusetts General Hospital or have a hematologic malignancy and are being seen as an outpatient.
What is the current status of trial NCT02512666?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2015-09. Estimated completion is 2017-09.
What interventions are being tested in trial NCT02512666?
The interventions under investigation include: AM4113-N5UT Dino-Lite (DEVICE).
Who is sponsoring clinical trial NCT02512666?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.